\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ abdominal\\ examination\\ with\\ negative\\ murphy\\'s\\ sign\\.\ \(0\)\
\-\ since\\ the\\ gallbladder\\ polyp\\ identified\\ is\\ solitary\\ and\\ measures\\ slightly\\ larger\\ than\\ 5\\ mm\\ \\(but\\ less\\ than\\ 10\\ mm\\)\\ it\\ should\\ be\\ monitored\\ with\\ follow\\-up\\ ultrasonography\\ to\\ ensure\\ its\\ stability\\.\\ \\ according\\ to\\ some\\ texts\\,\\ gallbladder\\ polyps\\ that\\ are\\ 5\\ mm\\ or\\ smaller\\ require\\ no\\ treatment\\ or\\ follow\\-up\\,\\ those\\ that\\ are\\ greater\\ than\\ 5\\ mm\\ but\\ less\\ than\\ 10\\ mm\\ require\\ monitoring\\ and\\ those\\ that\\ are\\ 10\\ mm\\ or\\ larger\\ should\\ be\\ removed\\ even\\ though\\ most\\ will\\ prove\\ to\\ be\\ benign\\ with\\ only\\ a\\ small\\ percentage\\ being\\ malignant\\.\ \(0\)\
\-\ a\\ small\\ \\(approximately\\ 5\\ mm\\)\\,\\ nonmobile\\,\\ intraluminal\\ polypoid\\ mass\\ adherent\\ to\\ the\\ nondependent\\ portion\\ of\\ the\\ gallbadder\\ wall\\ demonstrating\\ the\\ typical\\ \\"ball\\ on\\ the\\ ball\\"\\ sign\\ of\\ a\\ cholesterol\\ polyp\\.\\ \\ no\\ acoustic\\ shadowing\\ is\\ observed\\.\\ \\ the\\ common\\ bile\\ duct\\ is\\ not\\ dilated\\.\ \(0\)\
\-\ gallbladder\\ polyp\ \(6\)\
\-\ cholesterol\\ polyp\ \(3\)\
\-\ adenoma\ \(519\)\
\-\ papilloma\ \(115\)\
\-\ leiomyoma\ \(85\)\
\-\ lipoma\ \(291\)\
\-\ neuroma\ \(42\)\
\-\ cholelithiasis\ \(35\)\
\-\ sludge\\ ball\ \(3\)\
\-\ metastasis\\ \\(especially\\ melanoma\\)\ \(0\)\
\-\ forty\\ two\\-year\\-old\\ male\\ with\\ intermittent\\ right\\ upper\\ quadrant\\ abdominal\\ pain\\ for\\ one\\ year\\.\ \(0\)\
\-\ a\\ solitary\\ gallbladder\\ polyp\\ was\\ identified\\ on\\ this\\ study\\.\\ \\ cholesterol\\ polyps\\ are\\ the\\ most\\ common\\ type\\ of\\ gallbladder\\ polyp\\,\\ usually\\ 5\\ mm\\ or\\ smaller\\ and\\ are\\ usually\\ multiple\\.\\ \\ this\\ polyp\\ was\\ slightly\\ larger\\ than\\ 5\\ mm\\ and\\ was\\ solitary\\,\\ which\\ requires\\ consideration\\ of\\ other\\ less\\ common\\ types\\ of\\ gallbladder\\ polyps\\ to\\ be\\ included\\ in\\ the\\ differential\\ diagnosis\\:\\ adenoma\\,\\ papilloma\\,\\ leiomyoma\\,\\ lipoma\\ and\\ neuroma\\.\\ \\ gallstones\\ and\\ sludge\\ balls\\ were\\ ruled\\ out\\ due\\ to\\ the\\ nonmobile\\ nature\\ of\\ the\\ lesions\\ during\\ patient\\ repositioning\\.\\ \\ the\\ lack\\ of\\ a\\ shadow\\ also\\ makes\\ gallstones\\ unlikely\\.\\ \\ \\ the\\ common\\ bile\\ duct\\ was\\ not\\ dilated\\.\\ \\ no\\ detectable\\ blood\\ flow\\ was\\ demonstrated\\ on\\ color\\ doppler\\ imaging\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polyp\\:\\ 0\\.1120063254529457\ \(0\)\
\-\ mm\\:\\ 0\\.09302551451037845\ \(0\)\
\-\ gallbladder\\:\\ 0\\.08103924123659535\ \(0\)\
\-\ cholesterol\\:\\ 0\\.05343079975958232\ \(0\)\
\-\ polyps\\:\\ 0\\.05109801576552742\ \(0\)\
\-\ ball\\:\\ 0\\.05084167872865314\ \(0\)\
\-\ 5\\:\\ 0\\.04934527149560849\ \(0\)\
\-\ nonmobile\\:\\ 0\\.04354140688572551\ \(0\)\
\-\ solitary\\:\\ 0\\.04185007347496495\ \(0\)\
\-\ larger\\:\\ 0\\.04060892820566528\ \(0\)\
\-\ neuroma\\:\\ 0\\.0397561164587284\ \(0\)\
\-\ than\\:\\ 0\\.03682646142957687\ \(0\)\
\-\ sludge\\:\\ 0\\.0368200170993309\ \(0\)\
\-\ gallstones\\:\\ 0\\.034240792837646535\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.033100847302948926\ \(0\)\
\-\ bile\\:\\ 0\\.030046205144191703\ \(0\)\
\-\ common\\:\\ 0\\.029424568578373646\ \(0\)\
\-\ texts\\:\\ 0\\.028998415868310846\ \(0\)\
\-\ less\\:\\ 0\\.02855861846371068\ \(0\)\
\-\ 10\\:\\ 0\\.028427212779739246\ \(0\)\
\-\ papilloma\\:\\ 0\\.028248222677088538\ \(0\)\
\-\ smaller\\:\\ 0\\.02725453677305652\ \(0\)\
\-\ nondependent\\:\\ 0\\.026718326458574186\ \(0\)\
\-\ gallbadder\\:\\ 0\\.026718326458574186\ \(0\)\
\-\ two\\-year\\-old\\:\\ 0\\.026718326458574186\ \(0\)\
\-\ lipoma\\:\\ 0\\.02628445301553593\ \(0\)\
\-\ duct\\:\\ 0\\.025774201473786753\ \(0\)\
\-\ require\\:\\ 0\\.02572528714163203\ \(0\)\
\-\ those\\:\\ 0\\.02558068907111377\ \(0\)\
\-\ adenoma\\:\\ 0\\.023476936525039554\ \(0\)\
\-\ prove\\:\\ 0\\.02310447024585014\ \(0\)\
\-\ forty\\:\\ 0\\.02310447024585014\ \(0\)\
\-\ slightly\\:\\ 0\\.022725172751691267\ \(0\)\
\-\ balls\\:\\ 0\\.02259739564115521\ \(0\)\
\-\ repositioning\\:\\ 0\\.021424122799251488\ \(0\)\
\-\ dilated\\:\\ 0\\.02042823293810282\ \(0\)\
\-\ detectable\\:\\ 0\\.02031730623141855\ \(0\)\
\-\ identified\\:\\ 0\\.020088598955173165\ \(0\)\
\-\ adherent\\:\\ 0\\.0198780582293642\ \(0\)\
\-\ percentage\\:\\ 0\\.019490614033126095\ \(0\)\
\-\ sign\\:\\ 0\\.019476621722132045\ \(0\)\
\-\ are\\:\\ 0\\.01915910974555266\ \(0\)\
\-\ polypoid\\:\\ 0\\.019144033389514824\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.018289717048958827\ \(0\)\
\-\ ultrasonography\\:\\ 0\\.01828099304587176\ \(0\)\
\-\ should\\:\\ 0\\.017922424617689472\ \(0\)\
\-\ murphy\\:\\ 0\\.01749674625822374\ \(0\)\
\-\ be\\:\\ 0\\.017338904254525382\ \(0\)\
\-\ usually\\:\\ 0\\.01707189640701815\ \(0\)\
\-\ monitored\\:\\ 0\\.016947226242884382\ \(0\)\
\-\ ensure\\:\\ 0\\.01633345665215934\ \(0\)\
\-\ was\\:\\ 0\\.016254564510093533\ \(0\)\
\-\ shadow\\:\\ 0\\.0160009036361351\ \(0\)\
\-\ intraluminal\\:\\ 0\\.01593824510004729\ \(0\)\
\-\ acoustic\\:\\ 0\\.015757127411945224\ \(0\)\
\-\ stability\\:\\ 0\\.01569890511885509\ \(0\)\
\-\ consideration\\:\\ 0\\.01569890511885509\ \(0\)\
\-\ according\\:\\ 0\\.015641695438881838\ \(0\)\
\-\ cholelithiasis\\:\\ 0\\.015641695438881838\ \(0\)\
\-\ ruled\\:\\ 0\\.015641695438881838\ \(0\)\
\-\ makes\\:\\ 0\\.015585463750199929\ \(0\)\
\-\ monitoring\\:\\ 0\\.015530177176790783\ \(0\)\
\-\ shadowing\\:\\ 0\\.014930435213652771\ \(0\)\
\-\ requires\\:\\ 0\\.014930435213652771\ \(0\)\
\-\ that\\:\\ 0\\.014565599294988388\ \(0\)\
\-\ melanoma\\:\\ 0\\.014345957656950625\ \(0\)\
\-\ types\\:\\ 0\\.014345957656950625\ \(0\)\
\-\ abdominal\\:\\ 0\\.01405210025080339\ \(0\)\
\-\ color\\:\\ 0\\.01372081422639844\ \(0\)\
\-\ doppler\\:\\ 0\\.013596668410665388\ \(0\)\
\-\ observed\\:\\ 0\\.013477038002208563\ \(0\)\
\-\ unlikely\\:\\ 0\\.013390086498694895\ \(0\)\
\-\ nature\\:\\ 0\\.013305374340463267\ \(0\)\
\-\ or\\:\\ 0\\.013177930907417203\ \(0\)\
\-\ though\\:\\ 0\\.013037790000154212\ \(0\)\
\-\ most\\:\\ 0\\.0129791785640005\ \(0\)\
\-\ included\\:\\ 0\\.01296158256830706\ \(0\)\
\-\ small\\:\\ 0\\.012951153186717884\ \(0\)\
\-\ lack\\:\\ 0\\.012790344535556886\ \(0\)\
\-\ removed\\:\\ 0\\.012673269058245364\ \(0\)\
\-\ even\\:\\ 0\\.012516062927204743\ \(0\)\
\-\ demonstrating\\:\\ 0\\.012202542598901044\ \(0\)\
\-\ intermittent\\:\\ 0\\.012065868247213963\ \(0\)\
\-\ measures\\:\\ 0\\.012027839226157792\ \(0\)\
\-\ but\\:\\ 0\\.011990153296273273\ \(0\)\
\-\ especially\\:\\ 0\\.011569740320455464\ \(0\)\
\-\ typical\\:\\ 0\\.011271206230756569\ \(0\)\
\-\ its\\:\\ 0\\.010607011327156714\ \(0\)\
\-\ greater\\:\\ 0\\.010558277492337174\ \(0\)\
\-\ metastasis\\:\\ 0\\.01052219515230239\ \(0\)\
\-\ since\\:\\ 0\\.01032488362400729\ \(0\)\
\-\ portion\\:\\ 0\\.010181600813681205\ \(0\)\
\-\ malignant\\:\\ 0\\.010160100909142437\ \(0\)\
\-\ quadrant\\:\\ 0\\.009892683993375178\ \(0\)\
\-\ being\\:\\ 0\\.009795355186843942\ \(0\)\
\-\ benign\\:\\ 0\\.009700823575767108\ \(0\)\
\-\ type\\:\\ 0\\.009475737593246415\ \(0\)\
\-\ out\\:\\ 0\\.009289650910718802\ \(0\)\
\-\ flow\\:\\ 0\\.009289650910718802\ \(0\)\
\-\ study\\:\\ 0\\.00924878735809197\ \(0\)\
\-\ differential\\:\\ 0\\.008924209964976742\ \(0\)\
\-\ will\\:\\ 0\\.008794345455194546\ \(0\)\
\-\ examination\\:\\ 0\\.008738233669324228\ \(0\)\
\-\ approximately\\:\\ 0\\.00869676916630126\ \(0\)\
\-\ during\\:\\ 0\\.008602004111591474\ \(0\)\
\-\ some\\:\\ 0\\.008535948203509076\ \(0\)\
\-\ no\\:\\ 0\\.008491225171419097\ \(0\)\
\-\ only\\:\\ 0\\.00845201203448992\ \(0\)\
\-\ to\\:\\ 0\\.008428975824532623\ \(0\)\
\-\ negative\\:\\ 0\\.00839513210978577\ \(0\)\
\-\ demonstrated\\:\\ 0\\.008248092047555814\ \(0\)\
\-\ wall\\:\\ 0\\.008141970790259034\ \(0\)\
\-\ not\\:\\ 0\\.008123807050933785\ \(0\)\
\-\ \\,\\:\\ 0\\.008014442729130218\ \(0\)\
\-\ blood\\:\\ 0\\.0076724048437805895\ \(0\)\
\-\ one\\:\\ 0\\.007617537445100802\ \(0\)\
\-\ lesions\\:\\ 0\\.007524870086657722\ \(0\)\
\-\ due\\:\\ 0\\.007500911687344867\ \(0\)\
\-\ on\\:\\ 0\\.007143661306237776\ \(0\)\
\-\ \\(\\:\\ 0\\.0071285696668802025\ \(0\)\
\-\ \\)\\:\\ 0\\.007041490382697089\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.006908338939578346\ \(0\)\
\-\ upper\\:\\ 0\\.006783159557133942\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.006775491782836325\ \(0\)\
\-\ imaging\\:\\ 0\\.00658576915939343\ \(0\)\
\-\ a\\:\\ 0\\.006523023056226995\ \(0\)\
\-\ other\\:\\ 0\\.006479074173363317\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006454668851251381\ \(0\)\
\-\ were\\:\\ 0\\.00638252084437474\ \(0\)\
\-\ this\\:\\ 0\\.0063232711402245595\ \(0\)\
\-\ it\\:\\ 0\\.00631858021227966\ \(0\)\
\-\ \\'s\\:\\ 0\\.006197521770944227\ \(0\)\
\-\ multiple\\:\\ 0\\.0059204144851291735\ \(0\)\
\-\ treatment\\:\\ 0\\.005689529472371339\ \(0\)\
\-\ is\\:\\ 0\\.005548922155112423\ \(0\)\
\-\ also\\:\\ 0\\.005541511821283393\ \(0\)\
\-\ the\\:\\ 0\\.005457208606722071\ \(0\)\
\-\ which\\:\\ 0\\.005247186142245226\ \(0\)\
\-\ male\\:\\ 0\\.005082912953577214\ \(0\)\
\-\ normal\\:\\ 0\\.004406619916444411\ \(0\)\
\-\ mass\\:\\ 0\\.003909411207064357\ \(0\)\
\-\ \\:\\:\\ 0\\.0037180092631271876\ \(0\)\
\-\ and\\:\\ 0\\.003552809323662206\ \(0\)\
\-\ pain\\:\\ 0\\.003432921603719522\ \(0\)\
\-\ year\\:\\ 0\\.003145083122608272\ \(0\)\
\-\ right\\:\\ 0\\.002965893779968476\ \(0\)\
\-\ patient\\:\\ 0\\.0028177366148565393\ \(0\)\
\-\ of\\:\\ 0\\.0026826533078484175\ \(0\)\
\-\ for\\:\\ 0\\.002398382067903668\ \(0\)\
\-\ \\.\\:\\ 0\\.001634847057114631\ \(0\)\
\-\ with\\:\\ 0\\.001539528632761707\ \(0\)\
\-\ in\\:\\ 0\\.0013861750991455753\ \(0\)\
